Molecular Docking and Computational Analysis of Chemical Constituents of Tinospora cordifolia as Potential DPP-4 Inhibitors for Diabetes Management.
DOI:
https://doi.org/10.52783/jns.v14.3518Keywords:
Tinospora cordifolia, DPP-4 inhibitors, Molecular docking, AutoDock VINA, Diabetes, 8 Hydroxytinosporide, 10-Hydroxycolumbin, Computational drug design, Phytochemicals, Natural productsAbstract
Tinospora cordifolia, a well-known medicinal plant, has been traditionally used for its wide range of therapeutic properties, including antidiabetic effects. In this study, we investigated the potential of five key chemical constituents of Tinospora cordifolia—10-Hydroxycolumbin, 11-Hydroxymustakone, 20-Beta-Hydroxyecdysone, 8-Hydroxytinosporide, and AMRITOSIDE-A—as inhibitors of dipeptidyl peptidase-4 (DPP-4), a key enzyme in glucose metabolism. Molecular docking simulations were performed using AutoDock VINA, and the results were analyzed for binding affinity, hydrogen bonding, and hydrophobic interactions. Among the compounds tested, 8-Hydroxytinosporide showed the highest docking score (-9.0 kcal/mol) with extensive interactions, followed by 10-Hydroxycolumbin and 20-Beta-Hydroxyecdysone. The interactions of these compounds with DPP-4 suggest their potential as natural DPP-4 inhibitors. Although Amritoside-A and 11-Hydroxymustakone demonstrated weaker binding affinities, further optimization of these compounds could enhance their activity. This study provides valuable insights into the antidiabetic potential of Tinospora cordifolia and supports its exploration as a source of novel DPP-4 inhibitors for diabetes therapy.
Downloads
Metrics
References
Ninama R, Verma A, Mishra M, Nagle A, Pati RK, Meshram R. An exploration of physiological, medicinal and safety aspects of Guduchi (Tinospora cordifolia): A complete Ayurvedic and modern review. Journal of Ayurveda and Integrated Medical Sciences. 2022 Jun 27;7(4):62-74.
Modi B, Kumari Shah K, Shrestha J, Shrestha P, Basnet A, Tiwari I, Prasad Aryal S. Morphology, biological activity, chemical composition, and medicinal value of Tinospora cordifolia (willd.) Miers. Advanced Journal of Chemistry-Section B. 2020;2020:36-54.
Aranha I, Clement F, Venkatesh YP. Immunostimulatory properties of the major protein from the stem of the Ayurvedic medicinal herb, guduchi (Tinospora cordifolia). Journal of ethnopharmacology. 2012 Jan 31;139(2):366-72.
González-Castelazo F, Soria-Jasso LE, Torre-Villalvazo I, Cariño-Cortés R, Muñoz-Pérez VM, Ortiz MI, Fernández-Martínez E. Plants of the Rubiaceae family with effect on metabolic syndrome: Constituents, pharmacology, and molecular targets. Plants. 2023 Oct 15;12(20):3583.
Batiha GE, Akhtar N, Alsayegh AA, Abusudah WF, Almohmadi NH, Shaheen HM, Singh TG, De Waard M. Bioactive compounds, pharmacological actions, and pharmacokinetics of genus Acacia. Molecules. 2022 Oct 28;27(21):7340.
Ye S, Gao Y, Hu X, Cai J, Sun S, Jiang J. Research progress and future development potential of Flammulinavelutipes polysaccharides in the preparation process, structure analysis, biology, and pharmacology: A review. International Journal of Biological Macromolecules. 2024 Apr 8:131467.
Patel TP, Rawal K, Bagchi AK, Akolkar G, Bernardes N, Dias DD, Gupta S, Singal PK. Insulin resistance: an additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes. Heart failure reviews. 2016 Jan;21:11-23.
Farmaki P, Damaskos C, Garmpis N, Garmpi A, Savvanis S, Diamantis E. Complications of the type 2 diabetes mellitus. Current cardiology reviews. 2020 Nov 1;16(4):249-51.
Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, Ostolaza H, Martín C. Pathophysiology of type 2 diabetes mellitus. International journal of molecular sciences. 2020 Aug 30;21(17):6275.
Ahmed KA, Muniandy S, Ismail IS. Type 2 diabetes and vascular complications: A pathophysiologic view. Biomedical Research. 2010 Apr 1;21(2):147-55.
Nasr NE, Sadek KM. Role and mechanism (s) of incretin-dependent therapies for treating diabetes mellitus. Environmental Science and Pollution Research. 2022 Mar;29(13):18408-22.
Yin R, Xu Y, Wang X, Yang L, Zhao D. Role of dipeptidyl peptidase 4 inhibitors in antidiabetic treatment. Molecules. 2022 May 10;27(10):3055.
Gheonea TC, Șurlin P, Nicolae FM, Gheorghe DN, Popescu DM, Rogoveanu I. Dipeptidyl-Peptidase-4 and Glucagon-like-Peptide-1, a Link in the Connection between Periodontitis and Diabetes Mellitus—What Do We Know So Far?—A Scoping Review. Journal of Clinical Medicine. 2024 Feb 4;13(3):903.
Tarantola E, Bertone V, Milanesi G, Capelli E, Ferrigno A, Neri D, Vairetti M, Barni S, Freitas I. Dipeptidylpeptidase-IV, a key enzyme for the degradation of incretins and neuropeptides: activity and expression in the liver of lean and obese rats. European journal of histochemistry: EJH. 2012 Oct 8;56(4):e41.
Abubakar M, Nama L, Ansari MA, Ansari MM, Bhardwaj S, Daksh R, Syamala KL, Jamadade MS, Chhabra V, Kumar D, Kumar N. GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimer's Disease through its Supporting DPP4 Inhibitors: A Review. Current Topics in Medicinal Chemistry. 2024 Jul 1;24(19):1635-64.
González-Ruiz D, Gohlke H. Targeting protein-protein interactions with small molecules: challenges and perspectives for omputational binding epitope detection and ligand finding. Current medicinal chemistry. 2006 Sep 1;13(22):2607-25.
Chen X, Yan CC, Zhang X, Zhang X, Dai F, Yin J, Zhang Y. Drugtarget interaction prediction: databases, web servers and computational models. Briefings in bioinformatics. 2016 Jul 1;17(4):696-712.
Stanzione F, Giangreco I, Cole JC. Use of molecular docking computational tools in drug discovery. Progress in medicinal chemistry. 2021 Jan 1;60:273-343.
Palma PN, Krippahl L, Wampler JE, Moura JJ. BiGGER: a new (soft) docking algorithm for predicting protein interactions. Proteins: Structure, Function, and Bioinformatics. 2000 Jun 1;39(4):372-84.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
